-
-
Updated Evaluation of Global Progress Towards HBV and HCV Elimination, Preliminary Data Through 2021
-
Population Adjusted Prevalence of Hepatitis Delta Virus in 16 Countries and Territories
A lot more needs to be done for countries to meet all the GHSS 2030 targets. To achieve these goals, governments need to increase screening and treatment
-
Cost-Effectiveness Analysis of Treating All HBsAg+ Individuals in the United States
-
Global HBV Cascade of Care: The Pre-COVID-19 Baseline
English 
Spanish 
French 
Chinese 
Russian 
Arabic